Lysophosphatidic acid and endothelin-induced proliferation of ovarian cancer cell lines is mitigated by neutralization of granulin–epithelin precursor (GEP), a prosurvival factor for ovarian cancer (original) (raw)
References
Alper O, Hacker NF and Cho-Chung YS . (1999). Oncogene, 18, 4999–5004.
Amsterdam A, Gold RS, Hosokawa K, Yoshida Y, Sasson R, Jung Y and Kotsuji F . (1999). Trends Endocrinol. Metab., 10, 255–262.
Bagnato A, Salani D, Di Castro V, Wu-Wong JR, Tecce R, Nicotra MR, Venuti A and Natali PG . (1999). Cancer Res., 59, 720–727.
Bagnato A, Tecce R, Di Castro V and Catt KJ . (1997). Cancer Res., 57, 1306–1311.
Bagnato A, Tecce R, Moretti C, Di Castro V, Spergel D and Catt KJ . (1995). Clin. Cancer Res., 1, 1059–1066.
Bateman A, Belcourt D, Bennett H, Lazure C and Solomon S . (1990). Biochem. Biophys. Res. Commun., 173, 1161–1168.
Bateman A and Bennett HP . (1998). J. Endocrinol., 158, 145–151.
Cho YS, Kim MK, Cheadle C, Neary C, Becker KG and Cho-Chung YS . (2001). Proc. Natl. Acad. Sci. USA, 98, 9819–9823.
Daub H, Weiss FU, Wallasch C and Ullrich A . (1996). Nature, 379, 557–560.
Davidson B, Alejandro E, Florenes VA, Goderstad JM, Risberg B, Kristensen GB, Trope CG and Kohn EC . (2004). Cancer, 100, 2139–2147.
Del Bufalo D, Di Castro V, Biroccio A, Salani D, Rosano L, Spinella F and Bagnato A . (2002a). Clin. Sci. (London), 103 (Suppl 48), 302S–305S.
Del Bufalo D, Di Castro V, Biroccio A, Varmi M, Salani D, Rosano L, Trisciuoglio D, Spinella F and Bagnato A . (2002b). Mol. Pharmacol., 61, 524–532.
Enserink JM, Christensen AE, de Rooij J, van Triest M, Schwede F, Genieser HG, Doskeland SO, Blank JL and Bos JL . (2002). Nat. Cell Biol., 4, 901–906.
Fang X, Schummer M, Mao M, Yu S, Tabassam FH, Swaby R, Hasegawa Y, Tanyi JL, LaPushin R, Eder A, Jaffe R, Erickson J and Mills GB . (2002). Biochim. Biophys. Acta., 1582, 257–264.
Goetzl EJ, Dolezalova H, Kong Y and Zeng L . (1999). Cancer Res., 59, 4732–4737.
Guirland C, Buck KB, Gibney JA, DiCicco-Bloom E and Zheng JQ . (2003). J. Neurosci., 23, 2274–2283.
He Z and Bateman A . (2003). J. Mol. Med., 81, 600–612.
He Z, Ong CH, Halper J and Bateman A . (2003). Nat. Med., 9, 225–229.
Herrlich A, Daub H, Knebel A, Herrlich P, Ullrich A, Schultz G and Gudermann T . (1998). Proc. Natl. Acad. Sci. USA, 95, 8985–8990.
Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, Feuer EJ and Thun MJ . (2004). CA. Cancer J. Clin., 54, 8–29.
Jones MB, Michener CM, Blanchette JO, Kuznetsov VA, Raffeld M, Serrero G, Emmert-Buck MR, Petricoin EF, Krizman DB, Liotta LA and Kohn EC . (2003). Clin. Cancer Res., 9, 44–51.
Kang G, Joseph JW, Chepurny OG, Monaco M, Wheeler MB, Bos JL, Schwede F, Genieser HG and Holz GG . (2003). J. Biol. Chem., 278, 8279–8285.
Keiper M, Stope MB, Szatkowski D, Bohm A, Tysack K, Vom Dorp F, Saur O, Oude Weernink PA, Evellin S, Jakobs KH and Schmidt M . (2004). J. Biol. Chem., 279, 46497–46508.
Kim S, Jee K, Kim D, Koh H and Chung J . (2001). J. Biol. Chem., 276, 12864–12870.
Kopperud R, Krakstad C, Selheim F and Doskeland SO . (2003). FEBS Lett., 546, 121–126.
Liotta LA, Espina V, Mehta AI, Calvert V, Rosenblatt K, Geho D, Munson PJ, Young L, Wulfkuhle J and Petricoin E Fr . (2003). Cancer Cell, 3, 317–325.
Lu R and Serrero G . (1999). Biochem. Biophys. Res. Commun., 256, 204–207.
Lu R and Serrero G . (2000). Proc. Natl. Acad. Sci. USA, 97, 3993–3998.
Lu R and Serrero G . (2001). Proc. Natl. Acad. Sci. USA, 98, 142–147.
McDaid HM, Cairns MT, Atkinson RJ, McAleer S, Harkin DP, Gilmore P and Johnston PG . (1999). Br. J. Cancer, 79, 933–939.
Mei FC, Quai J, Tsygankova OM, Meinkoth JL, Quilliam LA and Cheng X . (2002). J. Biol. Chem., 277, 11497–11504.